28 octubre 2014
A large analysis of over 40,000 individuals on statin treatment has identified two new genetic variants which influence how ‘bad’ cholesterol levels respond to statin therapy. Statins are widely prescribed to patients and have been shown to lower bad cholesterol levels by up to 55%, making them a highly effective method of reducing risk of heart disease. However, despite this success, patient response can vary widely.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/GmnNqd2Mk7I/141028122602.htm
